- 01

Eli Lilly und Gesellschaft
LLYNew York
$1.1 Billionen
+4.4% 1W·+56.6% 1Y
- 02

Johnson & Johnson (J&J)
JNJNew York
$616 Milliarden
+5.7% 1W·+32.3% 1Y
- 03

AbbVie GmbH
ABBVNew York
$504 Milliarden
+0.6% 1W·+24.3% 1Y
- 04

F. Hoffmann-La Roche AG
ROGSIX
$372 Milliarden
-6.0% 1W·— 1Y
- 05

Merck & Co. GmbH
MRKNew York
$360 Milliarden
+1.4% 1W·+72.1% 1Y
- 06

Novartis AG
NOVNSIX
$286 Milliarden
+2.4% 1W·+14.6% 1Y
- 07

AstraZeneca AG
AZNNew York
$257 Milliarden
+3.5% 1W·-3.2% 1Y
- 08

Pfizer GmbH
PFENew York
$169 Milliarden
+3.3% 1W·— 1Y
- 09

Sanofi AG
SNYNew York
$97.3 Milliarden
+2.2% 1W·-19.8% 1Y
- 10

Jiangsu Hengrui Pharmaceuticals
600276Shanghai
$46.4 Milliarden
-1.3% 1W·-23.6% 1Y
- 11

Shanhe Pharmacaps
300452Shenzhen
$443 Millionen
-5.6% 1W·— 1Y
- 12

Tasly Pharmaceutical Group Co., Ltd.
600535Shanghai
—
— 1W·— 1Y
Zeige 1–12 von 12
